News
TRAX ▲ +2.9% - First Tracks Biotherapeutics, Inc.
TRAX ▲ +2.9% - First Tracks Biotherapeutics, Inc.
$TRAX reported Q3 2026 EPS of -$0.88, beating the -$0.89 estimate by 1.1%. Revenue was $0. No analyst estimate was published for revenue.
03-NOV-2026 04:28 PM ET
Share this post
More filings for $TRAX
TRAX ▲ +2.9% - First Tracks Biotherapeutics, Inc.Nov 3, 2026TRAX ▲ +2.9% - First Tracks Biotherapeutics, Inc.Nov 3, 2026TRAX - First Tracks Biotherapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026TRAX ▲ +5.0% - First Tracks Biotherapeutics, Inc.Oct 15, 2026TRAX ▲ +41.1% - First Tracks Biotherapeutics, Inc.Oct 12, 2026TRAX ▼ -0.7% - First Tracks Biotherapeutics, Inc.Oct 11, 2026
View full $TRAX filing history →💬 Comments
Loading comments…
Leave a comment